Possible withdrawal from endogeneous opiates in schizophrenics.
D005260:Female; D006801:Humans; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced*; D013997:Time Factors
D009270:Naloxone; D009271:Naltrexone